Lupin unveils partial onset seizures drug Eslicarbazepine Acetate in US
Mumbai: Global pharma major Lupin Limited has announced that the company has launched Eslicarbazepine Acetate Tablets, 200 mg, 400 mg, 600 mg, and 800 mg, following the approval of its Abbreviated New Drug Application (ANDA) from the U.S. FDA. The product is indicated for the treatment of partial-onset seizures in patients 4 years of age and […]